|
1 Rudan I, Boschi-Pinto C, Biloglav Z, et al. Epidemiology and etiology of childhood pneumonia[R]. Bull World Health Organ, 2008, 86(5)：408-416.
|
|
2 McIntosh K. Community-acquired pneumonia in children[J]. N Engl J Med, 2002, 346(6)：429-437.
|
|
3 World Health Organization. Pneumococcal conjugated vaccine for childhood immunization-WHO position paper[R]. Wkly Epidemiol Rec, 2007，82 (12)：L93-104.
|
|
4 British Thoracic Society of Standards of Care Committee. British Thoracic Society Guidelines for the management of community acquired pneumonia in childhood[J]. Thorax, 2002，57(Suppl 1)：il-24.
|
|
5 Juven T, Mertsola J, Waris M, et al. Etiology of community-acquired pneumonia in 254 hospitalized children[J]. Pediatr Infect Dis J, 2000，19(4)：293-298.
|
|
6 Centers for Disease Control and Prevention(CDC). Vaccine preventable deaths and the global immunization vision and strategy, 2006-2015[R]. MMWR Morb Mortal Wkly Rep，2006，55 (18)：511-515.
|
|
7 Centers for Disease Control and Prevention. Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine: United States, 1997-2006[R]. MMWR Morb Mortal Wkly Rep, 2009，58(1)：1-4.
|
|
8 Vuori-Holopainen E, Peltola H. Reappraisal of lung tap: Review of an old method for better etiologic diagnosis of childhood pneumonia[J]. Clin Infect Dis, 2001，32(5)：715-726.
|
|
9 Centers for Disease Control and Prevention. Progress in lntroduction of pneumococcal conjugate vaccine --- worldwide, 2000-2008[R]. MMWR Morb Mortal Wkly Rep, 2008, 57(42)：1148-1151.
|
|
10 Doern GV, Heilmann KP, Huynh HK, et al. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-95[J]. Antimicrob Agents Chemother，2001, 45(6)：1721-1729.
|
|
11 Richter SS, Heilmann KP, Dohrn CL, et al. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005[J]. Clini Infect Dis , 2009，48(3): e23-33.
|
|
12 Wang H, Sun HL, Chen MJ, et al. Resistance surveillance of common community respiratory pathogens isolated from 9 teaching hospitals in China, 2005-2006. Chin J Lab Med, 2007, 30(11): 1242-1247. [王辉，孙宏莉，陈民钧，等. 2005-2006年我国九家教学医院分离的常见呼吸道病原菌的耐药监测研究[J].中华检验医学杂志，2007, 30(11): 1242-1247.]
|
|
13 Wang L, Shen XZ, Lu Q, et al. Susceptibility Surveillance of Gram-positive Bacteria to Antibiotics Among Children in China: A Study in Beijing，Shanghai，Guangzhou and Chongqing during the Period of 2000-2006. J Capit Med Univ, 2008, 29(5): 626-631. [汪玲，沈叙庄，陆权，等. 4地儿科临床分离革兰阳性球菌2000-2006年耐药性监测[J].首都医科大学学报，2008，29(5)：626-631.]
|
|
14 Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement[M]. Wayne: CLSI, 2008, M100-S18.
|
|
15 Macgowan AP. On behalf of the BSAC Working Parties on Resistance Surveillance. Clinical implications of antimicrobial resistance for therapy[J]. J Antimicrob Chemother, 2008，62: ii05-ii114.
|
|
16 Wenger JD. Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada[J]. Pediatr Infect Dis J, 1998, 17(9 Suppl)：S132-136.
|
|
17 Kalies H, Siedler A, Gröndahl B, et al. Invasive Haemophilus influenzae infections in Germany: Impact of non-type b serotypes in the post-vaccine era[J]. BMC Infect Dis, 2009，9：45.
|
|
18 Harrison CJ, Woods C, Stout G, et al. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalispaediatric isolates from 2005 to 2007 to commonly used antibiotics[J]. J Antimicrob Chemother, 2009，63 (3)：511-519.
|
|
19 Zhang H, Li WH, Wang CQ, et al. Chinet 2007 surveillance of antimicrobial resisitance in Haemophilus influenzae in China. Chin J Infect Chemother, 2009, 9(3): 207-209. [张泓，李万华，王传清，等. 2007中国CHINET流感嗜血杆菌耐药性监测[J].中国感染与化疗杂志，2009，9(3)：207-209.]
|
|
20 Jansen WT, Verel A, Beitsma M, et al. Longitudinal European surveillance study of antibiotic resistance of Heamophilus influenzae[J]. J Antimicrob Chemother, 2006，58(4): 873-877.
|
|
21 Verduin CM, Hol C, Fleer A, et al. Moraxella catarrhalis: From emerging to established pathogen[J]. Clin Microbiol Rev, 2002, 15(1)：125-144.
|
|
22 Murphy TF, Parameswaran GI. Moraxella catarrhalis, a human respiratory tract pathogen[J]. Clin Infect Dis, 2009, 49(1)：124-131.
|
|
23 Wang Y, Zhang MH, Shen XZ, et al. Antibacterial agents resistance and typing of β-lactamases in moraxella catarrhalis. Chin J Lab Med, 2005, 28(6): 645-647. [王艳，张美和，沈叙庄，等.卡他莫拉菌耐药性与β内酰胺酶分型[J].中华检验医学杂志，2005, 28(6)：645-647.]
|
|
24 Deshpande LM, Sader HS, Fritsche TR, et al. Contemporary prevalence of BRO b-lactamases in Moraxella catarrhalis：Report from the SENTRY antimicrobial surveillance program (North America, 1997 to 2004)[J]. J Clin Microbiol，2006, 44(10)：3775-3777.
|
|
25 Johnson DM, Sader HS, Fritsche TR, et al. Susceptibility trends of Haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents：Five-year report from the SENTRY Antimicrobial Surveillance Program[J]. Diagn Microbiol Infect Dis, 2003, 47(1), 373-376.
|
|
26 Grundmann H, Aires-de-SousaM, Boyce J, et al. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat [J]. Lancet, 2006, 368 ( 9538) : 874-885.
|
|
27 Bassetti M, Nicco E, Mikulska M. Why is community-associated MRSA spreading across the world and how will it change clinical practice[J]? Int J Antimicrob Agents, 2009, 34(Suppl 1)：S15-19.
|
|
28 Centers for Disease Control and Prevention：Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-minnesota and North Dakota, 1997-1999[J]. MMWR Morb Mortal Wkly Rep，1999，48(N0 MM32)：707-710.
|
|
29 Vardakas KZ, Matthaiou DK, Falagas ME. Incidence, characteristics and outcomes of patients with severe CA-MRSA pneumonia[J]. Eur Respir J，2009，34(5)：1148-1158..
|
|
30 Dietrich DW, Auld DB, Mermel LA. Community-acquired methicillin-resistant Staphylococcus aureus in southern New England children[J]. Pediatrics, 2004，113(4)：e347-352.
|
|
31 Chen CJ, Huang YC. Community-acquired methicillin-resistant Staphylococcus aureus in Taiwan [J]. J Microbiol Immunol Infect, 2005, 38 (6)：376-382.
|
|
32 Baba T, Takeuchi F, Kuroda M, et al. Genome and virulence determinants of high virulence community-acquired methicillin-resistant Staphylococcus aureus[J]. Lancet ，2002, 359 (9320): 1819 -1827.
|
|
33 Eady EA, Cove JH. Staphylococcal resistance revisited: Community-acquired methicillin resistant Staphylococcus aureus-an emerging problem for the management of skin and soft tissue infections[J]. Curr Opin Infect Dis，2003，16(2)：103-124.
|
|
34 http：//www.rivm.nl/earss/result/Monitoring_reports/Annual_reports.jsp. EARSS annual report (2006)．
|
|
35 Zhu DM, Wang F, Zhang YY. Surveillance of bacterial resistance from hospitals in Shanghai in 2003. Chin J Infect Chemother, 2005, 5(4): 195. [朱德妹，汪复，张婴元. 2004年上海地区细菌耐药性监测[J].中国抗感染化疗杂志，2005，5(4)：195-200.]
|
|
36 Wang L, Lu Q, Wang CQ, et al. Susceptibility of Gram－positive bacteria to antimicrobial drugs among pediatric in China: An analysis of hospital data from Beijing, Shanghai, Guangzhou and Chongqing 2002－2004. Chin J Evid Based Pediatr, 2006, 1(2): 113-121. [汪玲，陆权，王传清，等. 2000～2004年京沪穗渝5家儿童医院革兰阳性球菌耐药情况分析[J]．中国循证儿科杂志，2006, 1 (2) : 113-121.]
|
|
37 Cosgrove SE, Sakoulas G, Perencevich EN，et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis[J]. Clin Infect Dis, 2003，36 (1)：53-59.
|
|
38 Hiramatsu K, Hanaki H, Ino T, et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility[J]. J Antimicrob Chemother, 1997，40(1)：135-136.
|
|
39 Centers for Disease Control and Prevention(CDC). Staphylococcus aureus resistant to vancomycin-United States, 2002[R]. MMWR Morb Mortal Wkly Rep, 2002，51(26)：565-567.
|
|
40 Clinical and Laboratory Standards Institute. Performance Standards for antimicrobial susceptibility testing: Sixteenth informational supplement. CLSI document M100-S16. Vol 26[M]. Pennsylvania: Clinical and Laboratory Standards Institute, 2006, 1-177.
|
|
41 Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: Antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007[J]. Infect Control Hosp Epidemiol, 2008, 29(11)：996-1011.
|
|
42 Sun JY, Ni YX, Wang F, et al. CHINET 2007 surveillance of antimicrobial resistance in Pseudomonas aeruginosa in China. Chin J Infect Chemother, 2009, 9(3): 192-195. [孙景勇，倪语星，汪复，等. 2007年中国CHINET铜绿假单胞菌耐药性监测[J].中国感染与化疗杂志，2009，9(3): 192-195.]
|
|
43 Li WH, Zhang H, Kong J, et al. Analysis of antibiotic resistance in Pseudomonas aeruginosaisolates from children patients. Chin J Infect Chemother, 2009, 9(1): 63-66. [李万华，张泓，孔菁，等.儿童患者中分离的铜绿假单胞菌耐药性分析[J].中国感染与化疗杂志，2009，9(1)：63-66.]
|
|
44 Onguru P, Erbay A, Bodur H, et al. Imipenem-resistant Pseudomonas aeruginosa：Risk factors for nosocomial infections[J]. J Korean Med Sci, 2008，23(6)：982-987.
|
|
45 A report from the NNIS System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003[J]. Am J Infect Control, 2003, 31(8)：481-498.
|
|
46 Perez F, Hujer AM, Hujer KM, et al. Global challenge of multidrug-resistant Acinetobacter baumannii[J]. Antimicrob Agents Chemother, 2007, 51(10)：3471-3484.
|
|
47 Rosenthal VD, Maki DG, Jamulitrat S, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009[J]. Am J Infect Control, 2010, 38(2)：95-104.e2.
|
|
48 Wang F, Zhu DM, Hu FP, et al. CHINET 2008 surveillance of bacterial resistance in China. Chin J Infect Chemother, 2009, 9(5): 321-329. [汪复，朱德妹，胡付品，等. 2008年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志，2009，9(5)：321-329.]
|
|
49 Demir S, Soysal A, Bakir M, et al. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in paediatric wards：A nested case-control study[J]. J Paediatr Child Health, 2008，44(10)：548-553.
|
|
50 Shenoy S, Hegde A, Dominic SR, et al. An outbreak of extended spectrum beta-lactamase producing Klebsiella pneumoniae in a neonatal intensive care unit[J]. Indian J Pathol Microbiol, 2007，50(3)：669-670.
|
|
51 Jain A, Roy I, Gupta MK, et al. Prevalence of extended-spectrum beta-lactamase-producing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital[J]. J Med Microbiol, 2003，52(Pt 5)：421-425.
|
|
52 Zhuo C, Su DH, Zhu DM, et al. CHINET 2007 surveillance of antimicrobial resistance in. E coli and Klebsiella spp. Chin J Infect Chemother, 2009, 9(3): 185-191. [卓超，苏丹红，朱德妹，等. 2007年CHINET大肠埃希菌和克雷伯菌属耐药性监测[J].中国感染与化疗杂志，2009，9(3)：185-191.]
|
|
53 Falagas ME, Karageorgopoulos DE. Extended-spectrum beta-lactamase-producing organisms[J]. J Hosp Infect, 2009，73(4)：345-354.
|
|
54 Koksal F, Ak K, Kucukbasmaci O, et al. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital[J]. Chemotherapy, 2009，55(4)：293-297.
|
|
55 Tonkic M, Goic-Barisic I, Punda-Polic V. Prevalence and antimicrobial resistance of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae strains isolated in a university hospital in Split, Croatia[J]. Int Microbiol, 2005，8(2)：119-124.
|
|
56 Zahar JR, Lortholary O, Martin C, et al. Addressing the challenge of extended-spectrum beta-lactamases[J]. Curr Opin Investig Drugs, 2009，10(2)：172-180.
|